Actuate Therapeutics, Inc. Liquidation Value Calculator
Actuate Therapeutics, Inc.
Current Price: $2.53 (as of 2026-04-24)
Loading calculator data...
Advanced: All 120 XBRL Tags
Every XBRL tag from SEC EDGAR filings, grouped by financial statement type. total = may include children, fact = independent leaf value.
Balance Sheet
| Tag | Value | Unit | ||
|---|---|---|---|---|
| accounts_payable | ||||
| Accounts Payable Current total AccountsPayableCurrent |
$1.52M | USD | ||
| cash | ||||
| Cash And Cash Equivalents At Carrying Value total CashAndCashEquivalentsAtCarryingValue |
$13.16M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents total CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
$13.16M | USD | ||
| Cash Equivalents At Carrying Value total CashEquivalentsAtCarryingValue |
$13.16M | USD | ||
| current_liabilities | ||||
| Interest Payable Current total InterestPayableCurrent |
$27,018 | USD | ||
| Other Accrued Liabilities Current total OtherAccruedLiabilitiesCurrent |
$3.57M | USD | ||
| liabilities_current | ||||
| Liabilities Current total LiabilitiesCurrent |
$5.71M | USD | ||
| liabilities_total | ||||
| Liabilities total | $6.11M | USD | ||
| shares_outstanding | ||||
| Common Stock Shares Outstanding total CommonStockSharesOutstanding |
23.2M | shares | ||
Unmapped Tags (109)
| Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent | $3.57M | USD | ||
| Additional Paid In Capital AdditionalPaidInCapital | $162.53M | USD | ||
| Assets Assets | $14.04M | USD | ||
| Assets Current AssetsCurrent | $13.64M | USD | ||
| Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Common Stock Shares Authorized CommonStockSharesAuthorized | $200.00M | shares | ||
| Common Stock Shares Issued CommonStockSharesIssued | $23.25M | shares | ||
| Common Stock Value CommonStockValue | $23 | USD | ||
| Deferred Tax Assets Gross DeferredTaxAssetsGross | $41.97M | USD | ||
| Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet | $0 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards | $18.25M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic | $86.52M | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | $696,277 | USD | ||
| Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | $3.01M | USD | ||
| Deferred Tax Assets Other DeferredTaxAssetsOther | $1.67M | USD | ||
| Deferred Tax Assets Other Tax Carryforwards DeferredTaxAssetsOtherTaxCarryforwards | $83.51M | USD | ||
| Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch | $13.28M | USD | ||
| Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance | $41.97M | USD | ||
| Derivative Liabilities DerivativeLiabilities | $0 | USD | ||
| Investment Income Interest InvestmentIncomeInterest | $287,710 | USD | ||
| Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity | $14.04M | USD | ||
| Liabilities Noncurrent LiabilitiesNoncurrent | $404,991 | USD | ||
| Other Assets Noncurrent OtherAssetsNoncurrent | $392,491 | USD | ||
| Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare | $0 | USD/shares | ||
| Preferred Stock Shares Authorized PreferredStockSharesAuthorized | $10.00M | shares | ||
| Preferred Stock Shares Issued PreferredStockSharesIssued | $0 | shares | ||
| Preferred Stock Shares Outstanding PreferredStockSharesOutstanding | $0 | shares | ||
| Preferred Stock Value PreferredStockValue | $0 | USD | ||
| Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit | $-154.61M | USD | ||
| Stockholders Equity StockholdersEquity | $7.92M | USD | ||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | $6.05M | USD | ||
| Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense | $6.05M | USD | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | $4.52M | USD | ||
| Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance | $8.93M | shares | ||
| Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit | $0 | USD | ||
| Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable | $-512,536 | USD | ||
| Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities | $-300,145 | USD | ||
| Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet | $-70,957 | USD | ||
| Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | $20,250 | USD | ||
| Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities | $-2.35M | USD | ||
| Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets | $-82,282 | USD | ||
| Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets | $-110,548 | USD | ||
| Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities | $23.72M | USD | ||
| Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities | $-19.21M | USD | ||
| Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering | $0 | USD | ||
| Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts | $302,825 | USD | ||
| Proceeds From Convertible Debt ProceedsFromConvertibleDebt | $0 | USD | ||
| Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering | $0 | USD | ||
| Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock | $3.83M | USD | ||
| Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement | $4.59M | USD | ||
| Proceeds From Short Term Debt ProceedsFromShortTermDebt | $0 | USD | ||
| Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised | $34,115 | USD | ||
| Repayments Of Short Term Debt RepaymentsOfShortTermDebt | $0 | USD | ||
| Share Based Compensation ShareBasedCompensation | $6.05M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | $589,821 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | $6 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | $131,362 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | $0 | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | $0 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | $1.08M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | $1.84M | shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | $7 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue | $820,334 | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | $7 | USD/shares | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | $1.14M | USD | ||
| Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | $1.84M | shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | $2 | USD/shares | ||
| Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | $7 | USD/shares | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | $3.13M | shares | ||
| Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit | $0 | USD | ||
| Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit | $0 | USD | ||
| Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit | $800 | USD | ||
| Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit | $800 | USD | ||
| Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit | $-4.08M | USD | ||
| Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit | $0 | USD | ||
| Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit | $4.15M | USD | ||
| Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit | $-68,960 | USD | ||
| Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther | $8.77M | USD | ||
| Earnings Per Share Basic EarningsPerShareBasic | $-1 | USD/shares | ||
| Earnings Per Share Diluted EarningsPerShareDiluted | $-1 | USD/shares | ||
| Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | $-0 | pure | ||
| Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | $0 | pure | ||
| Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments | $-0 | pure | ||
| General And Administrative Expense GeneralAndAdministrativeExpense | $12.20M | USD | ||
| Income Taxes Paid Net IncomeTaxesPaidNet | $800 | USD | ||
| Income Tax Expense Benefit IncomeTaxExpenseBenefit | $800 | USD | ||
| Income Tax Paid Federal After Refund Received IncomeTaxPaidFederalAfterRefundReceived | $0 | USD | ||
| Income Tax Paid State And Local After Refund Received IncomeTaxPaidStateAndLocalAfterRefundReceived | $800 | USD | ||
| Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | $5.01M | USD | ||
| Income Tax Reconciliation Nondeductible Expense Other IncomeTaxReconciliationNondeductibleExpenseOther | $99,100 | USD | ||
| Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch | $-440,198 | USD | ||
| Interest Expense Nonoperating InterestExpenseNonoperating | $20,250 | USD | ||
| Net Income Loss NetIncomeLoss | $-22.23M | USD | ||
| Nonoperating Income Expense NonoperatingIncomeExpense | $267,460 | USD | ||
| Operating Expenses OperatingExpenses | $22.50M | USD | ||
| Operating Income Loss OperatingIncomeLoss | $-22.50M | USD | ||
| Operating Lease Expense OperatingLeaseExpense | $51,200 | USD | ||
| Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent | $483,996 | USD | ||
| Research And Development Expense ResearchAndDevelopmentExpense | $10.29M | USD | ||
| Accrued Bonuses Current AccruedBonusesCurrent | $588,304 | USD | ||
| Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding | $922,096 | shares | ||
| Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants | $0 | USD | ||
| Interest Paid Net InterestPaidNet | $70,957 | USD | ||
| Number Of Operating Segments NumberOfOperatingSegments | $1 | Integer | ||
| Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues | $4.59M | USD | ||
| Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised | $34,115 | USD | ||
| Unrecognized Tax Benefits UnrecognizedTaxBenefits | $0 | USD | ||
| SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding | $1.14M | USD |
Showing balance sheet tags only. Liquidation analysis uses balance sheet data.